INTRODUCTION
Endocytosis plays a central role in cell physiology and pathology [1] [2] [3] . The pathways followed by materials internalized by its three main modes (fluid-phase endocytosis, receptor-mediated endocytosis, and phagocytosis) have been amply delineated and the complexity of the underlying protein machineries and their interaction motives are becoming increasingly unraveled [4] . In contrast, kinetic aspects of endocytosis have received comparatively less attention even though rate-limiting interactions between molecular actors and subcellular compartments are crucial for cell homeostasis and disease and their study is often illuminating [5] [6] [7] [8] .
Dissection of the endocytosis machinery has greatly benefited from genetic approaches. These, however, have clear limitations. First, mutations affecting proteins involved in the regulation of endocytosis generally show pleiotropic effects and affect more than one specific route or step in endocytosis [9 -15] . Multiplicity of effects possibly reflects the facts that (i) the overall function of the endocytic apparatus is coordinated, (ii) the same actors are involved at many steps, and/or (iii) interacting motives are being shared by more than one actor. Second, dominant-positive or -negative transfection does not equally affect all cells in a population and may trigger compensatory mechanisms [16] . Third, the effects of transfection can hardly be titrated and may be indirect [17] . Selective inhibitors of endocytosis that cause a rapid and uniform response and allow for titration of its effects therefore remain of great interest. For example, drugs interfering with vacuolar acidification (e.g., chloroquine, monensin, or bafilomycin A1), affecting microtubules (e.g., nocodazole), or causing storage disorders such as phospholidosis have been instrumental in dissecting routes from endosomes to lysosomes [7, 18 -26] . With respect to the internalization step, the cholesterol-complexing agent, methyl-␤-cyclodextrin, was shown to inhibit receptor-mediated endocytosis and, at higher concentrations, to affect bulk-phase endocytosis. When studied, drugs were 1 Present address: Department of Membrane Cell Biology, Faculty of Medical Sciences, University of Groningen, Groningen, The Netherlands. 2 To whom correspondence and reprint requests should be addressed. Fax: ϩ32-2-764. 75 . 43 . E-mail: courtoy@cell.ucl.ac.be.
shown to also affect regurgitation or phagocytosis [27] [28] [29] [30] .
Using primary cultures of rat fetal fibroblasts, we recently reported that the dicationic acid-stable macrolide antibiotic, azithromycin [31, 32] , markedly inhibits fluid-phase uptake of horseradish peroxidase (HRP) and subsequent transfer to lysosomes, without affecting regurgitation [33] . It was also noticed that azithromycin caused an extensive vacuolation of late endocytic compartments. This prompted us to extend this analysis to receptor-mediated endocytosis and phagocytosis. For this purpose, we selected the established murine macrophage-like cell line, J774, in which fluid-phase endocytosis, receptor-mediated endocytosis, and phagocytosis have all been extensively characterized [34 -36] . The effects of azithromycin were addressed using (i) two classical and unrelated tracers of fluid-phase endocytosis, HRP and lucifer yellow (LY) [35, 37] ; (ii) two validated and unrelated tracers of receptor-mediated endocytosis, transferrin [38] and peroxidase-anti-peroxidase immune complexes (PAP) [39, 40] , that respectively explore constitutive internalization of the transferrin receptor followed by recycling vs ligand-induced entry of Fc␥ receptor into the degradative pathway; and (iii) Texas red-labeled latex beads as a well-accepted tracer of phagocytosis [41] .
Azithromycin was found (i) to inhibit fluid-phase endocytosis (HRP and LY) in a concentration-dependent manner; (ii) to down-regulate surface transferrin receptors and to delay the transfer of receptor-bound ligands (transferrin and PAP) into primary endocytic vesicles or the recycling route, but not to inhibit their subsequent rate of internalization or recycling per se; (iii) to impair the transfer of solutes taken up by fluidphase or receptor-mediated endocytosis into lysosomes; but (iv) not to affect phagocytosis nor fusion of phagosomes with lysosomes.
MATERIALS AND METHODS
Cell culture and viability. The J774 macrophage cell line, derived from a mouse reticulosarcoma [42] , was cultured in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS). Unless stated otherwise, cells were seeded at 5.5 ϫ 10 4 cells/cm 2 and grown until confluency (2 days) before exposure to 100 mg/L (132 M) azithromycin for 3 h. Cells were then washed and transferred to fresh medium containing the appropriate tracer but no azithromycin, since its effects lasted for at least 3 h after drug withdrawal (see Fig.2B ). General toxicity was evaluated by cellular ATP level, plasma membrane integrity (release of lactate dehydrogenase), and DNA and protein syntheses, as described [33] .
Fluid-phase endocytosis. HRP uptake and regurgitation were studied exactly as described earlier [33] . The same procedure was used for LY, except that cells were washed three times for 30 s with PBS supplemented with 0.1% (w/v) bovine serum albumin (BSA) and four times with PBS (yielding a 99% release of LY bound to cells at 4°C). Uptake of LY was measured on sonicated cell lysates prepared in 0.05% (v/v) Triton X-100 by fluorimetry (Perkin-Elmer LS-30 fluorescence spectrophotometer; Beaconsfield, UK; exc 430 nm, em 540 nm). Since the uptake of both tracers proved strictly linear with their extracellular concentration in the range used, short-term experiments were performed at higher concentration than long-term studies. Values were then normalized to both cell protein content and to a nominal 1 mg/ml tracer concentration, in order to allow for direct comparison and provide equivalents to clearance values.
Receptor-mediated endocytosis. Iron-saturated transferrin was labeled by 125 I with iodobeads [43] to a specific radioactivity of 800 -1300 cpm/ng of protein. Surface binding isotherm was determined after incubating cells precooled at 4°C with increasing concentrations of 125 I-transferrin in FCS-free medium supplemented with 1% BSA for 1 h, followed by three washes in ice-cold PBS-Ca 2ϩ -Mg 2ϩ (PBS supplemented with 3.6 mM CaCl 2 and 3 mM MgSO 4 ). Radioactivity was measured in cell lysates prepared in 0.01% Triton X-100 (1275 Mini-Gamma counter; LKB Wallac, Sollentuna, Sweden). Nonspecific binding, estimated by incubating cells with a 300-fold excess of cold transferrin, never exceeded 30% of the total cell-associated counts and was subtracted. For internalization studies, 50 nM 125 Itransferrin was allowed to bind at 4°C for 1 h, then cells were reincubated at 37°C in prewarmed medium without FCS but containing 1% BSA for the indicated intervals, followed by three washes at 4°C with PBS-Ca 2ϩ -Mg 2ϩ . Sensitivity to subsequent Pronase digestion (1 h at 4°C; 3 mg/ml in RPMI) was used to distinguish between surface-accessible vs intracellular transferrin [5] ; this method removed 96.6% of the amount bound at 4°C to untreated cells, but up to 99.7% for azithromycin-treated cells. Recycling of 125 I-transferrin was studied after binding at 4°C, internalization in transferrin-free medium for 3 min at 37°C, washing at 4°C, and reincubation in transferrin-free medium at 37°C for up to 60 min, as described [23] .
For binding and internalization of PAP immune complexes, the same procedure was used, except that (i) binding at 4°C was extended for 2 h, (ii) nonspecific binding at 4°C was measured by competition with a 100-fold mass (ϳ250-fold molar) excess of mouse IgG, and (iii) surface-accessible was distinguished from internalized ligand upon subsequent displacement by excess mouse IgG at 4°C for 1 h (yielding 90% removal of the material initially bound at 4°C). Attempts at surface digestion with Pronase (3 mg/ml), trypsin (1 mg/ml), bromelain (3 mg/ml), or acid stripping at pH 3.0 proved ineffective if performed at 4°C.
Phagocytosis of latex beads. Cells were incubated at 37°C with carboxylate-modified latex beads of two different sizes covalently coupled to Texas red (1 and 0.1 m in diameter). After five washes for 30 s with PBS at 4°C (removing more than 90% of the beads bound at 4°C), uptake of beads was measured on sonicated cell lysates by fluorimetry ( exc 575 nm; em 610 nm).
Western blotting. Washed cells were lysed in 0.5% (w/v) sodium deoxycholate, 0.1% (w/v) SDS, and 1% (v/v) nonionic detergent (Igepal CA-630) in the presence of protease inhibitors (phenylmethylsulfonyl fluoride, aprotinin, and sodium orthovanadate), resolved by SDS-PAGE under denaturing and reducing conditions (NuPAGE antioxidant), and analyzed by standard Western blotting procedures, using blocking in 1% (w/v) nonfat milk and 0.025% (v/v) Tween 20, overnight incubation at 4°C with mouse anti-human transferrin receptor monoclonal antibody (cross-reacting with the murine transferrin receptor; 1:250), followed by anti-mouse HRP-conjugated secondary antibodies (1:750) and revealed by chemiluminescence (ECL kit; Amersham, Buckinghamshire, UK).
Other biochemical assays. Proteins were measured by the Lowry procedure. Azithromycin was assayed by a disc-plate microbiological technique, as described in Montenez et al. [44] . Because of the large accumulation of azithromycin in cells (see Results), we checked that a 10-fold excess of drug in the final assay mixtures over that contributed by lysates from treated cells caused no interference in all biochemical assays. Chloroquine was assayed on sonicated cell lysates by fluorimetry ( exc 335 nm; em 378 nm) after precipitation of proteins with trichloroacetic acid and addition of NaOH to reach pH 10 (adapted from [45] Peroxidase cytochemistry and ultrastructural microscopy. These were performed exactly as described [33] .
Confocal imaging of living cells. Fluid-phase endocytosis, receptor-mediated endocytosis, and phagocytosis were tracked in living cells using 1 mg/ml rhodamine-HRP, 10 mg/ml Alexa Fluor 568 -PAP immune complexes, and 2500 beads/l Texas red-labeled beads (0.1 m in diameter), respectively. Table 1 shows that azithromycin at 100 mg/L (132 M) caused no significant change in ATP cell content, LDH release, or [ 3 H]leucine and [ 3 H]thymidine incorporation after a 3-h preincubation. These conditions were therefore used for most subsequent experiments.
RESULTS

Azithromycin Does Not Cause Overall Toxicity in J774 Mouse Macrophages
Azithromycin Severely Inhibits Fluid-Phase Endocytosis in J774 Macrophages
It was first verified that both HRP and LY satisfied the basic criteria for tracers of fluid-phase endocytosis in J774 macrophages. These criteria included: (i) a strictly linear accumulation over a large range of concentrations (up to 4 mg/ml for HRP and 3 mg/ml for LY) and intersecting the ordinate exactly at its origin, (ii) a constant rate of accumulation (up to at least 4 h), and (iii) an apparent clearance at steady state (long- term accumulation) indistinguishable for both tracers (11.2 Ϯ 1.6 and 11.4 Ϯ 1.3 nl ⅐ min Ϫ1 ⅐ mg cell protein Ϫ1 ; n ϭ 4; NS; this value is comparable to that reported in the same cells for LY [35] ). Figure 1A shows that pretreatment with 100 mg/L azithromycin for 3 h markedly impaired endocytosis of both tracers (clearance decreased by ϳ70% at any time between 15 min and 4 h for a given concentration). After 2 h of tracer uptake, the same level of inhibition was seen over the entire range of concentration investigated (0.5-4 mg/ml for HRP and 0.5-3 mg/ml for LY; data not shown). After shorter times of uptake (Ͻ15 min), i.e., when the regurgitated fraction is still incomplete [5] , both tracers showed in control cells a faster apparent clearance, even slightly faster for LY than for HRP measured strictly in parallel (Fig. 1B) , consistent with the molecular size fractionation mechanism analyzed in detail by Berthiaume et al. [6] . Figure 1B further shows that azithromycin also inhibited this early uptake (by ϳ65% for HRP and ϳ40% for LY at 2 min). The observation that very short-and long-term accumulation were both inhibited by azithromycin argues against an indirect effect due to primary acceleration of regurgitation. To further exclude this possibility, cells were loaded with HRP or LY for 15 min and then allowed to release the tracers in fresh medium for up to 60 min. The rate of efflux of both tracers was not significantly affected by azithromycin (data not shown). Figure 2 shows that the effect of azithromycin on HRP endocytosis was almost strictly linearly related to its intracellular content, as previously observed with fibroblasts [33] (this cellular content being itself directly proportional to the extracellular concentration, data not shown). Upon transfer of cells into drug-free medium, azithromycin release started rapidly but inhibition of HRP persisted for 3 h, after which it showed a delayed decrease that paralleled the loss of intracellular drug content (Fig. 2B ). This observation explains why it was possible to assess the influence of azithromycin on fluid-phase endocytosis at ϳ3 h after drug removal and allowed us to further rule out a direct effect of extracellular azithromycin by systematically performing all endocytosis/phagocytosis assays after 3 h azithromycin pretreatment followed by a 1-to 3-h postincubation in drug-free medium.
Additional experiments (data not shown) disclosed that (i) the inhibition of the endocytic uptake of both HRP and LY was maximal after 1 h of exposure to azithromycin and remained constant for up to 24 h of pretreatment with the drug, and (ii) no inhibition was seen if cells were pretreated with azithromycin together with 20 M monensin, a condition that almost entirely abrogated the cellular accumulation of azithromycin.
Azithromycin Severely Down-regulates Surface Transferrin Receptors, Slightly Delays Internalization of Transferrin, and Markedly Delays Its Recycling in J774 Macrophages
To address the effect of azithromycin on constitutive receptor-mediated endocytosis and recycling, transferrin uptake and efflux were studied. As shown in Fig.  3A , 125 I-transferrin binding at 4°C to untreated J774 macrophages reached saturation at ϳ1200 fmol ⅐ mg cell protein Ϫ1 , corresponding to ϳ75,000 binding sites ⅐ cell Ϫ1 with a single class of receptors exhibiting
FIG. 2. (A)
Correlation between inhibition of HRP endocytosis and azithromycin cell content in J774 macrophages in cells pretreated at increasing concentrations of azithromycin for 3 h and then challenged with HRP for 2 h in the absence of drug. (B) Persistence of the effect of a pretreatement with azithromycin on the inhibition of HRP uptake. Cells were pretreated with 100 mg/L azithromycin for 3 h, transferred to drug-free medium for the indicated times, and then challenged with HRP for 2 h without azithromycin; cell lysates were assayed in parallel for peroxidase activity (filled squares) and azithromycin content (filled circles). Experiments were reproduced three times with similar results. an apparent K d of ϳ15 nM, based on Scatchard plot analysis. To study endocytosis and recycling with maximal sensitivity, cells were surface-labeled with 50 nM 125 I-transferrin, washed, and reincubated at 37°C for the indicated intervals, after which they were transferred to 4°C and surface-digested with Pronase to distinguish the pool accessible at the plasma membrane (Pronase-sensitive) from the sequestered pool (Pronase-resistant) [46] . Pronase-resistant transferrin increased very rapidly to level off after ϳ4 min (Fig.  3B) . The ratio of Pronase-resistant to Pronase-sensitive counts, an index of internalization efficiency [47] , illustrates how fast surface-bound 125 I-transferrin was internalized in J774 cells (Ͼ60% in 2 min; Fig. 3C) , with an apparent equilibrium between the rapidly recycling pool and the plasma membrane pool being reached after ϳ4 min at a ratio of 1.2. Figure 3D shows that total internalized 125 I-transferrin is recycled from the combined rapidly and slowly recycling pools with a half-time of ϳ18 min.
Azithromycin treatment caused a dramatic decrease in the surface pool of transferrin-receptors, down to ϳ20% of control (Fig. 3A) , without detectable difference in apparent affinity (no significant change in K d value; Fig. 3A inset) . Intracellular sequestration of 125 Itransferrin at 37°C was dramatically decreased in absolute terms (Fig. 3B) , almost in proportion to the loss of surface receptor pool. Indeed, the internalization efficiency of surface-bound tracer was essentially unaffected (Fig. 3C) , except for a systematic delay of 0.5-1 min. In subsequent experiments, we observed that the extent of disappearance of transferrin surface receptors and of the delay in the internalization of transferrin were both directly related to the extracellular concentration of azithromycin during the pretreatment period (data not shown).
When recycling was studied after a 3-min pulse (without surface acid stripping), Pronase-resistant values first showed a paradoxical increase in azithromycin-treated cells, indicating that more surface-bound tracer entered the intracellular pool than the amount concomitantly lost by recycling. Moreover, recycling was remarkably delayed by ϳ10 min, after which essentially all intracellular transferrin was released into the extracellular medium with a somewhat accelerated kinetics (t 1/2 of ϳ12 min compared with ϳ18 min in control cells), as if compensating for the delayed efflux.
Azithromycin Marginally Affects the Surface Pool of Fc␥ Receptors but Markedly Delays Internalization of PAP Immune Complexes in J774 Cells
To address the effects of azithromycin on ligandinduced, receptor-mediated endocytosis into the degradation pathway, the dynamics of Fc␥ receptors was examined by following the binding and internalization of mouse PAP complexes, assayed by their peroxidase activity. In contrast to transferrin receptors, the internalization of Fc␥ receptors depends on ligand binding, after which ligand/receptor complexes are delivered to lysosomes [48] . PAP binding at 4°C showed saturation (Fig. 4A) , with a surface pool estimated at 850 ng ⅐ mg cell protein Ϫ1 , corresponding to ϳ220,000 ligand binding sites ⅐ cell Ϫ1 with a single class of receptors exhibiting an apparent K d of ϳ40 nM, based on Scatchard plot analysis and assuming a 1:1 ligand:receptor stoichiometry. These values are in agreement with a previous report [34] .
It is clear that the number of receptors would be underestimated and their affinity overestimated if each PAP immune complex interacted with more than one Fc␥ receptor. Although PAP complexes consist primarily of two IgG molecules with their Fc ends pointed to opposite directions and of three peroxidase molecules in the center of the complex, and are therefore potentially divalent, the steric arrangement of Fc ends does not favor both of them binding to neighboring Fc receptor in the same plasma membrane. Accordingly, PAP immune complexes have been regarded by some investigators as a monovalent ligand [39, 49] . However, to the best of our knowledge, the effective receptor valency of PAP immune complexes with respect to Fc␥ receptor at the cell surface is not yet established.
The surface pool of Fc␥ receptor was only marginally decreased upon azithromycin treatment (to ϳ185,000 sites ⅐ cell Ϫ1 ), with no detectable change in affinity (Fig.  4A inset) . In untreated cells, internalization of PAP at 37°C proceeded linearly for about 45 min (see kinetics over the first 20 min in Fig. 4B ) and then leveled off after ϳ1 h (not shown). In azithromycin-treated cells, PAP internalization was clearly delayed by ϳ10 min, after which its rate of accumulation became comparable to that of control cells (Fig. 4B ) and then reached essentially the same level after 1 h (not shown).
Azithromycin Causes No Apparent Loss but a Redistribution of Transferrin Receptors, While Fc␥ Receptors Are Unaffected
In view of the major decrease in the transferrinreceptor surface pool upon azithromycin treatment, Western blotting and confocal microscopy were used to examine whether the drug would modify the size of the total cellular pool of receptors or induce its redistribution. By Western blotting, a major band at M r 107,000 was clearly detected in both control and azithromycintreated cells (Fig. 5A) , together with an additional minor band at M r 31,000 (not shown), as reported by other investigators [50] . Densitometric scanning showed no significant difference in the abundance of the transferrin receptor in treated cells compared with controls (94 Ϯ 6%; n ϭ 4; NS). The same antibodies were then used for transferrin-receptor immunolocalization by confocal microscopy (Figs. 5B and 5C ). In control cells, staining was essentially associated with peripheral or perinuclear cytoplasmic dots, together with a faint labeling of the cell surface. This is consistent with the known distribution of the transferrin receptor, which prevalently occurs in endosomal structures involved in transferrin/receptor complex recycling and intracellular iron unloading, with a minor pool being exposed at the cell surface [38] . In azithromycin-treated cells, the intensity of immunolabeling and the size of these granular structures were apparently increased with a quasi-complete disappearance of the pericellular labeling, consistent with redistribution from a surface to an intracellular pool. In contrast, no detectable difference in the immunofluorescence pattern or intensity of Fc␥ receptors between control and azithromycin-treated cells could be evidenced (data not shown). Figure 6 shows the ultrastructural appearance of azithromycin-treated cells and the localization of HRP at 5 min (A, B) and 2 h (C) after tracer addition, as revealed by cytochemical staining. The most striking observation was the formation of several-micrometerswide electron-lucent vesicles scattered throughout the cytoplasm, concomitant with the almost complete disappearance of typical lysosomes. The Golgi apparatus was moderately swollen; but no other ultrastructural alteration was noticed; in particular, mitochondria and the endoplasmic reticulum appeared normal. The large vacuoles induced by azithromycin contained multiple membrane-bound profiles, including branched tubular invaginations, and were consistently devoid of peroxidase-reaction product. Even after 2 h of incubation with HRP, this tracer remained essentially restricted to tubulospherical endosomes of normal appearance; the few multivesicular and residual bodies that resisted vacuolation were also labeled after this interval (see Fig. 6C ). This was in sharp contrast with untreated cells, in which HRP was almost completely transferred from early endosomes to typical lysosomes (not shown), as is well known for macrophages [51] and fibroblasts [5, 33] .
Azithromycin Causes an Intense Vacuolation of J774 Macrophages; These Vacuoles Are Acidic and, Once Formed, Are Inaccessible to Newly Endocytosed HRP and PAP Complexes
The nature of the large vacuoles induced by azithromycin was further examined using LysoTracker Green DND-26, a fluorophore which concentrates in acidic cellular compartments such as late endosomes and ly- sosomes. When control cells were allowed to endocytose rhodamine-labeled HRP or Alexa-Fluor-labeled PAP complexes for 1 h and then exposed to LysoTracker green for 2 h in HRP-or PAP-free medium, LysoTracker green consistently stained small-sized vesicles scattered through the cytoplasm. Most of them also contained HRP or PAP complexes, resulting in a yellow color in the merged image (Fig. 7, left) . In azithromycin-treated cells, LysoTracker green was prominently concentrated in a few large vacuoles, which could exceed 10 m in diameter, and the intensity of LysoTracker green signal appeared somewhat inversely related with vacuolar size. Biochemical assays revealed that accumulation of LysoTracker (1.5 M) was decreased by about half upon azithromycin treatment (218 Ϯ 18 pmol ⅐ mg cell protein Ϫ1 vs 410 Ϯ 19 pmol ⅐ mg cell protein Ϫ1 in untreated cells; n ϭ 3; P Ͻ 0.01). LysoTracker-labeled vacuoles disappeared after overnight incubation in drug-free medium (not shown), at which time essentially all cell-associated drug had been released (see Fig. 2B ).
We further compared these properties of azithromycin with those of chloroquine, since the acidotropic effects of chloroquine have been most extensively studied [52, 53] . At 132 M chloroquine, a concentration known to decrease by half the acidification of endocytic organelles [53] , (i) this drug was concentrated in J774 cells ϳ100-fold, like azithromycin; (ii) chloroquine also induced the formation of vacuoles that showed homogeneous LysoTracker labelling, albeit vacuolation was less extensive than with azithromycin (vacuoles did not exceed 2-3 m in diameter); and (iii) in contrast with azithromycin, chloroquine did not decrease the net accumulation of 1.5 M LysoTracker (404 Ϯ 34 pmol/mg cell protein vs 410 Ϯ 19 pmol/mg cell protein in untreated cells; NS).
In good agreement with ultrastructural cytochemistry, azithromycin-treated cells showed complete segregation between rhodamine-HRP-labeled small vesicles and the large LysoTracker-labeled vacuoles (Fig. 7 , azithromycin pretreatment, upper row). Alexa PAPlabeled structures and LysoTracker-labeled vacuoles were similarly segregated. The small fluorescent vesicles containing HRP or PAP were often seen immediately around large vacuoles, as if preparing for docking (Fig. 7, azithromycin pretreatment, lower row) . Upon time-lapse imaging, however, these vesicles were seen to move quickly along large vacuoles without discernible fusion and content mixing (data not shown).
Whereas the large, LysoTracker-positive vacuoles induced by azithromycin were thus essentially inaccessible to HRP or PAP when these tracers were added to cells after the vacuoles had been formed, the converse was not true. Indeed, both HRP and PAP, having ended up in late endosomes/lysosomes after 1 h of uptake and an overnight chase (both in the absence of azithromycin), clearly localized within the vacuoles that developed upon subsequent exposure to the drug (Fig. 7, right) .
FIG. 7.
Live cell imaging of control and treated J774 macrophages. The fluid-phase endocytic tracer, HRP (rhodamine-labeled, upper row), and the receptor-mediated endocytic tracer, PAP (Alexa-Fluor-labeled, lower row), are seen in the red channel. The acidotropic marker, LysoTracker green, is seen in the green channel. Merged images combine signals of the red and green channels, which were recorded separately. Control: cells were incubated with the endocytic tracers for 1 h, then exposed to LysoTracker green for 2 additional hours in the absence of endocytic tracers. Azithromycin pretreatment; cells were treated with 100 mg/L azithromycin for 3 h, then incubated with the endocytic tracers for 1 h in the absence of azithromycin, and further exposed to LysoTracker green for 2 additional hours in the absence of endocytic tracers and of azithromycin. Azithromycin posttreatment: cells were first incubated with the endocytic tracers for 1 h, chased in tracer-free medium overnight, and then treated with 100 mg/L azithromycin for 3 h in the presence of LysoTracker green. Experiments were reproduced three times with similar results.
Azithromycin Affects neither Phagocytosis of Latex Beads nor Their Access to Azithromycin-Induced Vacuoles
The effect of azithromycin on phagocytosis was investigated by studying the accumulation of carboxylate-modified polystyrene latex beads covalently coupled with Texas red of large (1 m; 270 particles ⅐ nl Ϫ1 ) and small size (0.1 m; 230,000 particles ⅐ nl Ϫ1 , for equal sensitivity of detection). It was verified that uptake of 1-m latex beads was identical whether they were precoated or not with IgG or serum and whether phagocytosis took place in the presence of untreated serum, of heat-decomplemented serum, or in the absence of serum. Figure 8 shows that the rate of accumulation of the large beads was constant for at least 4 h (clearance of ϳ3 l ⅐ min Ϫ1 ⅐ mg cell protein Ϫ1 ). Accumulation of the small beads was comparable, albeit with a slightly faster initial clearance (ϳ6 l ⅐ min Ϫ1 ⅐ mg cell protein Ϫ1 at 15 min), followed by a slower clearance (2 l ⅐ min Ϫ1 ⅐ mg cell protein Ϫ1 at 4 h). As shown in Fig. 8 , pretreatment of the cells with azithromycin did not alter phagocytosis of large beads at any time and only marginally that of the small beads. After 2 h of uptake, there was no sign of saturation for the large beads up to 400 beads ⅐ nl Ϫ1 , but a tendency toward saturation for the small beads (ϳ40% deviation from linearity at 450,000 beads ⅐ nl Ϫ1 ). This could be easily explained by comparing the membrane area of the plasma membrane of J774 macrophages (ϳ1200 m 2 ) [54] with the estimated internalized membrane required to form the deduced number of 0.1-m phagosomes (ϳ630 m 2 ) compared with the 1-m phagosomes (ϳ125 m 2 ). Again, no significant effect of a pretreatment with azithromycin was noted (data not shown).
In the confocal microscope, the many small vesicles labeled in control cells by LysoTracker green were largely accessible to Texas red-labeled 0.1-m latex beads (Fig. 9A) . Azithromycin-pretreated cells also showed a clear colocalization of both tracers, and Texas red-labeled particles were detected as multiple dots within the large LysoTracker-containing vacuoles (Fig.  9B) . Occurrence of freely moving latex beads within these structures was further demonstrated by timelapse imaging (Fig. 9C) .
DISCUSSION
This report discloses several striking findings on the inhibitory effects of azithromycin on endocytosis and shows that this drug can exert distinct effects on its main pathways.
First, this study extends to the J774 mouse macrophage cell line preliminary evidence obtained by our laboratories on the inhibition by azithromycin of fluidphase endocytosis in primary cultures of rat fetal fibroblasts [33] . Based on an extensive set of biochemical data obtained with two unrelated tracers combined with morphological data by live-cell imaging and ultrastructural cytochemistry, the present observations demonstrate that azithromycin is an inhibitor of fluidphase endocytosis by selectively impairing the uptake of solutes in a dose-dependent manner. Although azithromycin further prevents their accessibility to lysosomes, it does not accelerate tracer regurgitation, in contrast to other perturbations or drugs that concomitantly block transfer to lysosomes and promote regurgitation [23] .
Second, the two crucial steps accounting for the selectivity of receptor-mediated endocytosis, namely the sequestration of ligand/receptor complexes into endocytic pits (as most obvious for PAP immune complexes) and the accessibility of transferrin to the recycling route, appear particularly vulnerable to azithromycin. In treated cells, the disproportion between the major delay in the accessibility of internalized transferrin to the recycling pathway, as opposed to the minor delay in receptor-mediated entry, easily accounts for the major decrease in the surface pool of transferrin receptors, without detectable loss of the total cell complement of receptors. In turn, the major decrease in the surface pool of transferrin receptors leads to a proportional inhibition of receptor-mediated endocytosis in absolute terms, which contrasts with an almost identical efficiency of internalization of receptor-bound ligands, except for the slight delay in primary sequestration. In retrospect, such a delay could be recognized for another weak base, methylamine, in the historical report of receptor-mediated endocytosis of ␣ 2 -macroglobulintrypsin/receptor complexes in macrophages [55] .
This delay suggests interference with lateral mobility (discussed below) and/or availability of a rate-limiting factor for coat recruitment [56] , e.g., a Rab protein acting as a timer [57] . Sensitivity to this delaying effect of azithromycin was higher for PAP immune complexes, possibly due to (i) the larger size of ligand/receptor complexes, (ii) the potential multivalency of the ligand, and/or (iii) different requirements for a ligand-induced process. Conversely, no delay was observed for receptormediated endocytosis of transferrin in rat fetal fibroblasts, possibly because internalization of receptor-bound ligands proceeds at an approximately fourfold slower rate than in J774 macrophages [8% ⅐ min Ϫ1 in fibroblasts [33] vs Ͼ 30% ⅐ min Ϫ1 (this report)]. Third, azithromycin clearly leaves the phagocytosis pathway completely unaffected, which is an interesting feature for an antibiotic in a clinical perspective, since phagocytosis of bacteria is an important component of a successful host defense against infection. This is consistent with other reports indicating that azithromycin does not impair the uptake of opsonized Staphylococcus aureus or zymosan [58, 59] and underlines that endocytosis and phagocytosis are distinct processes, governed, at least partly, by distinct machineries.
Fourth, azithromycin most conspicuously causes extensive vacuolation of the late, actively acidified endocytic compartments. That these vacuoles originate from late endosomes/lysosomes is strongly suggested by their labeling with LysoTracker green, their multivesicular and tubular content, and the concomitant disappearance of typical lysosomes and conversely, by vacuole disappearance and lysosome reappearance upon loss of cell-associated drug in chase experiments. We may reasonably assume that this vacuolation is caused by the massive accumulation of azithromycin in these acidic vacuoles and the ensuing increase in osmotic pressure. Azithromycin storage in lysosomes has been directly demonstrated in J774 macrophages exposed to lower concentrations of azithromycin (10 mg/L) using cell fractionation techniques [60] . This accumulation is not surprising since the drug is an amphiphilic molecule bearing two basic functions with appropriately weak pK a values [8.1 for the endocyclic tertiary amine and 8.8 for the tertiary amine carried by one of the two sugar moieties (desosamine)]. It is therefore susceptible, like chloroquine [45] and many other cationic amphiphiles, to accumulating in lysosomes and other acidic membrane-bound compartments by proton trapping [52] . As anticipated, accumulation of azithromycin was impaired by monensin, a drug known to collapse transmembrane pH gradients [61] .
Three lines of evidence suggest that azithromycin causes a more severe impairment of acidification than chloroquine: the stronger vacuolating effect of azithromycin compared with the same concentration of chloroquine, the lower accumulation of LysoTracker green in a biochemical assay, and the fainter green fluorescence by confocal microscopy. With respect to chloroquine, the net accumulation of LysoTracker identical to that in untreated cells suggests a strictly inverse relationship between vacuolation and impaired acidification.
Like azithromycin, chloroquine and primaquine (a close congener of chloroquine) inhibit fluid-phase endocytosis, cause the intracellular sequestration of transferrin receptor [62, 63] , and severely impair the accessibility of fluid-phase tracers to lysosomes [19] . That all three drugs are dicationic amphiphiles and have similar effects suggests a common mechanism: interference with the acidification of late endosomes and lysosomes (resulting in a defective recruitment the COP machinery required for the budding of endocytic carrier vesicles [64] ) or intense vacuolation (so that swollen late endosomes/lysosomes would become unable to fuse with incoming endosomes). Perturbation of endocytosis by vacuolation has already been observed with other basic drugs such as nicotine or procaine amide [65] but was not fully documented in terms of specificity toward one or several pathways of endocytosis. Biogenesis of phagolysosomes proceeds through sequential interactions between components of the endocytic apparatus [66] . These involve exchanges between newly formed phagosomes and early endosomes and the gradual acquisition of lysosome-like properties by repeated fusion with lysosomes as well as trans-Golgi network-derived vesicles [36] . The lack of inhibition by azithromycin on the accessibility of latex beads to lysosomes indicates that forces causing fusion of phagosomes, but not of endosomes, can overcome the increased membrane tension due to vacuolation of late endosomes/lysosomes.
This does not explain, however, some discrepancies between azithromycin and chloroquine [45] or sucrose [67] , which also cause extensive vacuolation of the late endocytic apparatus. In particular, azithromycin does not inhibit phagocytosis nor alter the accessibility of phagocytosed latex beads into lysosomes, in contrast with chloroquine [68, 69] , but similar to -COP-defective cells [70] . Moreover, interference with acidification and/or vacuolation do not directly account for two distinct properties of azithromycin that, it should be noted, could be evidenced even several hours after drug withdrawal. First, azithromycin delayed sequestration in clathrin-coated pits of receptor-bound ligands, as best evidenced for PAP/Fc␥ receptor complexes (ϳ10 min), but did not appreciably affect the subsequent rate of endocytosis per se. Second, azithromycin causes a major delay of transferrin-receptor recycling (ϳ10 min) without impairing the subsequent rate of efflux, which contrasts with the absence of reported delay but prolonged half-life of efflux of transferrin receptors in cells treated with monensin and bafilomycin A1 [7, 23, 24] , two drugs known to markedly impair acidification of endosomes and lysosomes [71, 72] .
Thus, to account for the delay in endocytic sequestration and recycling, more specific mechanims such as interference with coat components should be envisaged. One candidate might be dynamin, regarded as a "pinchase" [73] , but it is unlikely that azithromycin acts by interfering with its interaction with the plasma membrane, since dominant-negative dynamin causes a stable inhibition in the rate of receptor-mediated endocytosis and phagocytosis, but is rapidly compensated for with respect to fluid-phase endocytosis [11] [12] [13] . A second candidate could be Rab5, a rate-limiting catalyst of endocytosis. Dominant-negative Rab5 slows down fluid-phase endocytosis, but it inhibits to a comparable extent the rate of receptor-mediated endocytosis of transferrin [17] . Conversely, dominant-positive Rab5 accelerates phagocytosis [74, 75] . A third candidate is the COP complex. Some features of azithromycin-treated cells are indeed reminiscent of -COP inactivation in CHO cells, which (i) selectively inhibits fluid-phase endocytosis when measured after long intervals, (ii) may inhibit receptor-mediated endocytosis [76] , (iii) does not inhibit phagocytosis, and (iv) blocks transfer of a pinocytosed tracer to lysosomes, but not maturation of phagosomes [64, 70, 77] . However, -COP inactivation does not delay receptor-mediated endocytosis [76] (but see also [77] ). Alternatively, decreased lateral diffusion [78] or impaired membrane partitioning [79] could explain the delay of ligand-induced sequestration of Fc␥ receptor into clathrincoated vesicles and of incorporation of transferrin-receptor into recycling vesicles.
It is now well accepted that pinocytosis involves both clathrin-dependent and clathrin-independent pathways [80 -82] . In this context, azithromycin was found not to affect the steady-state efficiency of receptormediated endocytosis (i.e., the budding of clathrincoated pits into clathrin-coated vesicles), but to decrease by about half the rate of fluid-phase endocytosis. Since the latter reflects the sum of both clathrin-associated and clathrin-independent bulk-flow endocytosis, and since the rate of receptor-mediated endocytosis per se is not affected, one is led to conclude that azithromycin selectively inhibits clathrin-independent endocytosis. Phagosomes and clathrin-coated vesicles are clearly surrounded by a cytoplasmic coat that imposes a local constraint on membrane fluidity. For example, this coat protects clathrin-coated structures against "corrugation" by the cholesterol-complexing agent, filipin [83] . In contrast, no such coat has been reported so far for clathrin-independent endocytic vesicles. Bulkflow endocytosis may be affected not only by local lipid asymmetry across the bilayer, but also by physical forces such as tension and fluidity [84, 85] . That clathrin-independent endocytosis is particularly sensitive to such biophysical parameters is supported by its selective inhibition by low concentrations of PEG-cholesterol, whereas impairment of incurvation of clathrincoated pits requires higher concentrations [86, 87] . In this respect, interaction of azithromycin with membrane phospholipids is supported by direct in vitro evidence based on equilibrium dialysis with liposomes [88] .
Whereas it is clear that rigorous studies with pharmacological agents require several controls, it is suggested that azithromycin, or related agents, could be useful for kinetics studies addressing the contribution of clathrin-independent endocytosis [82] , sorting steps in the recycling pathway [89] , fusogenicity of phagosomes [90] , and possibly cell signaling [91] , as well as the roles and functions of the various endocytic pathways in pathology and pharmacotoxicology. 
